Milton S. Hershey Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Milton S. Hershey Medical Center sits in the top decile of US sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count).
Milton S. Hershey Medical Center: 396 sponsored US clinical trials, 55 recruiting.
Milton S. Hershey Medical Center sponsors 396 registered US clinical trials on ClinicalTrials.gov, 55 of them currently recruiting, and 255 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Child Abuse, with 4 trials.
Top-decile sponsor footprint
Milton S. Hershey Medical Center ranks in the top decile of sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
255 of 320 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
396 total, page 3 of 8
Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers
NCT03625986
Califormula Study: Calibrated Formula Feeding to Optimize Infant Growth
NCT05104073
Trial Assessing Light Intensity Exercise on the Health of Older Breast Cancer Survivors
NCT04965246
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
NCT04199728
Prevention of Oral DNA Damage by Black Raspberries
NCT04372914
A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma
NCT04003896
Evaluation of the Aevidum Curriculum and Club
NCT05018689
The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea (CINV) and Vomiting
NCT04478630
A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma
NCT04026568
Choosing an Effective Healthcare Spokesperson: An Interactive Intervention
NCT04599166
Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients
NCT04972916
Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH
NCT04872777
Low Nicotine Cigarettes Plus Electronic Cigarettes
NCT04058717
Functional Activity Strength Training
NCT05697497
HPV Vaccine Communication ECHO for Primary Care Clinics
NCT04587167
Effect of Preoperative Incentive Spirometer on Postoperative Pulmonary Complications Following Lung Resection
NCT04732143
St. Joe's Invitation Effectiveness Study
NCT04658888
Diminish Chemotherapy Related Side Effects Through Patient Education
NCT04694794
Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact
NCT04731441
Inclined Positioning and Infant Gastroesophageal Reflux
NCT04542239
Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas
NCT04471194
Nurse AMIE for Echo Show: Randomized Control Trial
NCT04673019
Self-Sampling for Human Papillomavirus (HPV) at Well Women Appointments
NCT04591977
Utilizing Novel Information Technology to Promote Exercise and Well-Being in Adolescents and Young Adults With Cancer
NCT03778658
Self-sampling for Human Papillomavirus (HPV) Among Patients Receiving Colposcopy
NCT04585243
COVID-19 Project ECHO in Nursing Homes
NCT04499391
Cannabidiol and Management of Endometriosis Pain
NCT04527003
Single-center, Double-arm, Prospective Clinical Trial to Compare Visual Performance of Non-diffractive Extended Vision and Neutral Aspheric Monofocal Intraocular Lenses
NCT04591054
Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE
NCT04569799
Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study
NCT04333810
reSET-O RCT (Randomized Controlled Trial)
NCT04129580
Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
NCT04006847
Effect of Formal Contraception Handouts
NCT03956030
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
NCT04514341
Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke
NCT04123067
Study Dynamic Haptic Robotic Trainer (DHRT) and DHRT+ for Central Venous Catherization Insertion Training for Surgical Residents
NCT04541446
Lavender Aromasticks for Pain Control
NCT04396444
Decreasing Stress in Diabetes
NCT04016415
Remote Physiologic Monitoring of Resident Wellness and Burnout
NCT04304703
Remote Pulmonary Function Testing and Nurse Coaching in ALS
NCT04490148
Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
NCT04002115
Liberal vs. Restricted Post-discharge Opioid Prescribing Following Midurethral Sling
NCT04277975
COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior
NCT04377581
Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation
NCT04112849
Surfactant Protein Genetic Variants in COVID-19 Infection
NCT04650191
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
NCT03612960
A Neurobiological Model of Anhedonia
NCT05629520
Exercise Therapy in Radiation Therapy
NCT03905356
Inositol Supplementation to Treat PCOS (INSUPP-PCOS)
NCT03864068
Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis
NCT03970330
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 33 |
| Phase 3 | 25 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the Milton S. Hershey Medical Center pipeline
55 recruiting of 396 indexed (14% open); 255 completed (64%).
Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).
Top condition: Child Abuse (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Milton S. Hershey Medical Center: open-pipeline peers nationwide
Peers matched on 396 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 396 trials (± recruiting share)
- Abramson Cancer Center at Penn Medicine · 402 trials · 18% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- Takeda · 408 trials · 12% recruiting
Sponsors near 14% open enrollment (± trial volume)
- University of Cincinnati · 14% recruiting · 245 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- BeiGene · 14% recruiting · 65 trials
- Seattle Institute for Biomedical and Clinical Research · 14% recruiting · 43 trials
Related
What to do with this Milton S. Hershey Medical Center page
396 registered trials is a research-attention snapshot, not an endorsement of Milton S. Hershey Medical Center or any single study.
- 55 of Milton S. Hershey Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Child Abuse is the condition Milton S. Hershey Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Child Abuse trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Milton S. Hershey Medical Center pipeline card: 396 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.